First CancerCoachLive event on August 4th with focus on Non-Hodgkin Lymphomas
NEEDHAM, MA (PRWEB) JULY 28, 2016
While so much effort goes into educating the public around cancer prevention, cancer remains largely unpredictable and many thousands each year will be diagnosed. When they are, one critical factor in treatment success is the time it takes to forming a patient’s response plan. As such, PlatformQ Health is launching a new education platform, CancerCoachLive, to empower newly diagnosed cancer patients.
In partnership with The Leukemia & Lymphoma Society, the inaugural CancerCoachLive program on August 4th will focus on Non-Hodgkin Lymphomas (NHL). About 70,00 people in the U.S. alone are diagnosed with NHL every year. And each of them needs to understand their subtype — which NHL has about 60 of — in order to determine the type of treatment they are facing. Of the two major subtypes, B-cell lymphoma represents roughly 85%. Educating B-cell lymphoma patients and their caregivers can not only improve treatment outcome, but help them to face such a life-changing circumstance with confidence.
Presented by leading medical faculty from the University of Nebraska and Dana-Farber Cancer Institute, the program will allow lymphoma patients and their caregivers to discuss and share their questions, experiences and get advice via CancerCoachLive’s virtual learning channel. It will also be available on demand after the live session.
Direct patient education is not new for PlatformQ Health, given its award-winning programs in Diabetic Retinopathy. However, its history is rooted in leading data-centric, high engagement online Continuing Medical Education sessions for clinicians. Robert Rosenbloom, CEO and Founder of PlatformQ Health, says, “We have seen enormous benefit to our clinician community who need easy access to the highest quality Continuing Medical Education. We are excited to bring the same rigorous standard of education to our patient programs at CancerCoachLive.”
“Education is one of the best tools we can provide to our patients. By educating them about their disease and treatments, they are able to make better decisions throughout their cancer journey,” Karen Demairo, Executive Director- Education & integration, LLS.
Partnering with a long-trusted advocacy organization like LLS means CancerCoachLive is helping meet the critical need newly diagnosed patients have for trustworthy education. With CancerCoachLive, organizations that serve cancer patients everywhere will be able to invite their members to participate in immersive, interactive online educational events that help empower them as they embark on their treatment journey.
Are you a patient or caregiver facing B-cell non-Hodgkin lymphoma? Join this expert panel on August 4, 2016 at 2PM EDT by registering here.
This activity is supported by an educational grant from Pharmacyclics LLC, an Abbvie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC and a grant from Genentech.